<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-16T23:40:44+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>CRISPR治疗痤疮！卢冠达联合创办的Eligo与GSK达成最新合作，交易总额2.24亿美元</title>
    <updated>2021-01-16T21:01:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/cgRmLJIdLmPM-e2jzSQebw</id>
    <link href="https://mp.weixin.qq.com/s/cgRmLJIdLmPM-e2jzSQebw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲斥资超10亿美元，拿下ILT2抗体！这款新型癌症免疫疗法究竟有何优势？</title>
    <updated>2021-01-15T21:11:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/A7ksYw-dJIzoWeutQy1q8A</id>
    <link href="https://mp.weixin.qq.com/s/A7ksYw-dJIzoWeutQy1q8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>主攻RNAi疗法！诺奖得主创立的Atalanta以1.1亿美元启动，与Biogen、罗氏已达成合作</title>
    <updated>2021-01-14T21:00:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/GN96L8Tos0cIRhjWTJBE9A</id>
    <link href="https://mp.weixin.qq.com/s/GN96L8Tos0cIRhjWTJBE9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“神刊”CA最新癌症统计：美国癌症死亡率连续第二年破纪录下降</title>
    <updated>2021-01-13T20:58:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/KEeMP4pNpFbrBBroUhKoew</id>
    <link href="https://mp.weixin.qq.com/s/KEeMP4pNpFbrBBroUhKoew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>常兴点评 | Nature里程碑：碱基编辑疗法获突破！治疗早衰症，小鼠寿命从7个月延长至1.5年</title>
    <updated>2021-01-12T20:59:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/T4FxxuaiIIV_D_kdJWyusw</id>
    <link href="https://mp.weixin.qq.com/s/T4FxxuaiIIV_D_kdJWyusw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1抗体“新搭档”——ENPP1抑制剂</title>
    <updated>2021-01-11T21:02:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/WuwbFh2Eg_dyA7h7vvJwLQ</id>
    <link href="https://mp.weixin.qq.com/s/WuwbFh2Eg_dyA7h7vvJwLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国科学家Science子刊最新成果：抗衰老新靶点—— KAT7</title>
    <updated>2021-01-10T21:00:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/3AGqyQqhUq6mLUbu-D4rzQ</id>
    <link href="https://mp.weixin.qq.com/s/3AGqyQqhUq6mLUbu-D4rzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>主攻CAR-NK！卢冠达创办的公司B轮融资1.05亿美元，开发下一代细胞和基因疗法</title>
    <updated>2021-01-09T20:58:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/YxK0dgULO7rXXqshGwgN3w</id>
    <link href="https://mp.weixin.qq.com/s/YxK0dgULO7rXXqshGwgN3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-M疗法人体试验启动！Carisma宣布完成4700万美元B轮融资，目标是实体瘤</title>
    <updated>2021-01-08T21:00:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/Ng46k3wEfH7-RMh5BFLuHw</id>
    <link href="https://mp.weixin.qq.com/s/Ng46k3wEfH7-RMh5BFLuHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell：一文揭示100多个PROTAC潜在靶点（附详细清单）</title>
    <updated>2021-01-07T21:00:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Ca8Szz6J5rPda4NK9sW44w</id>
    <link href="https://mp.weixin.qq.com/s/Ca8Szz6J5rPda4NK9sW44w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>